The global Western Blotting Market is estimated to be valued at US$ 759.5 Mn in 2023 and is expected to exhibit a CAGR of 6.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Western blotting is a molecular biology technique commonly used for detection and identification of specific proteins in a sample of tissue homogenate or extract. Western blotting provides a highly sensitive, specific, and quantitative analysis of target proteins, enabling researchers to study posttranslational modifications and interactions between proteins.
Market key trends:
Key trends in the western blotting market include increasing research in proteomics and proteomic analysis, which has boosted demand for western blotting techniques. Proteomic analysis techniques such as western blotting are widely utilized in developing vaccines, diagnostics, and therapeutics for various diseases. Growing incidence of chronic and infectious diseases is another factor driving market growth. Technological advancements in western blotting instruments offering higher sensitivity, specificity, and automation are also fueling market expansion. Introduction of semi-automated, fully automated, and chemiluminescence-based membrane substrates have enhanced western blotting applications in clinical and pharmaceutical research.
SWOT Analysis
Strengths: Digital detection systems have enhanced the accuracy, sensitivity and automation of Western blotting techniques.
Weaknesses: Western blot can be challenging in specific applications and often requires optimization of the protocol for new targets. Traditional gel-based assays can be time-consuming.
Opportunities: Growing proteomics research and need for personalized medicine drives demand for Western blotting for research applications. Scope for automation and microfluidics-based Western blotting techniques.
Threats: High performance platforms from competitive alternatives like LC-MS/MS for large-scale targeted proteomics applications. Price pressures in reagents markets.
Key Takeaways
The Global Western Blotting Market Size is expected to witness high growth, exhibiting CAGR of 6.8% over the forecast period, due to increasing demand for personalized medicine and proteomics research for disease diagnostics and drug discovery.
Regional analysis: North America accounted for the largest share of the Western blotting market in 2023 due to strong demand from biomedical research activities and pharmaceutical industries in the region. Asia Pacific region is expected to grow at fastest pace due to increasing R&D investments and expanding healthcare infrastructure and clinical diagnostics market in major countries like China and India.
Key players operating in the Western blotting market are Thermo Fisher Scientific, Inc., GE HealthCare, F. Hoffmann-La Roche Ltd, Lumigen, Inc., Merck KGaA, Bio-Rad Laboratories, Inc., LI-COR, Inc., Bio-Techne, SBH Sciences, Advansta Inc., Azure Biosystems Inc., HiMedia Laboratories., Elabscience Biotechnology Inc., GenScript, Cell Signaling Technology, Inc., ICL, Inc., Takara Bio Inc., Leinco Technologies.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
